Groundbreaking first human trial launches for new cancer fighter
NCT ID NCT07151040
Summary
This is the first-ever study in humans of a new experimental drug called TH9619 for people with advanced solid tumors. The trial aims to find a safe and effective dose while checking how the body processes the drug and whether it shows signs of fighting cancer. It's open to adults with specific advanced cancers who have already tried at least one standard treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario Fundacion Jimenez Diaz
RECRUITINGMadrid, Spain
-
Institut Gustave Roussy
RECRUITINGVillejuif, France
-
Newcastle University
RECRUITINGNewcastle upon Tyne, United Kingdom
-
Vall D Hebron Institute Of Oncology
RECRUITINGBarcelona, Spain
Conditions
Explore the condition pages connected to this study.